1,678
Views
21
CrossRef citations to date
0
Altmetric
Article

Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules

ORCID Icon, , , &
Pages 1139-1148 | Received 29 May 2020, Accepted 15 Sep 2020, Published online: 30 Sep 2020

References

  • Gharib H, Papini E, Paschke R, AACE/AME/ETA Task Force on Thyroid Nodules, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. J Endocrinol Invest. 2010;33(5):287–250.
  • Durante C, Grani G, Lamartina L, et al. The diagnosis and management of thyroid nodules: a review. JAMA. 2018;319(9):914–924.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.
  • Mauri G, Gennaro N, Lee MK, et al. Laser and radiofrequency ablations for benign and malignant thyroid tumors. Int J Hyperthermia. 2019;36(2):13–20.
  • Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20(1):11–22.
  • Bernardi S, Stacul F, Zecchin M, et al. Radiofrequency ablation for benign thyroid nodules. J Endocrinol Invest. 2016;39(9):1003–1013.
  • Deandrea M, Trimboli P, Garino F, et al. Long-term efficacy of a single session of RFA for benign thyroid nodules: a longitudinal 5-year observational study. J Clin Endocrinol Metab. 2019;104(9):3751–3756.
  • Trimboli P, Castellana M, Sconfienza LM, et al. Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis. Endocrine. 2020;67(1):35–43.
  • Khanh HQ, Hung NQ, Vinh VH, et al. Efficacy of microwave ablation in the treatment of large (≥3 cm) benign thyroid nodules. World J Surg. 2020;44(7):2272–2279.
  • Lang BHH, Woo YC, Chiu KW. Two-year efficacy of single-session high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules. Eur Radiol. 2019;29(1):93–101.
  • Kim JH, Baek JH, Lim HK, Guideline Committee for the Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology, et al. 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology. Korean J Radiol. 2018;19(4):632–655.
  • Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperthermia. 2019;36(1):376–382.
  • Dietrich CF, Müller T, Bojunga J, et al. Statement and recommendations on interventional ultrasound as a thyroid diagnostic and treatment procedure. Ultrasound Med Biol. 2018;44(1):14–36.
  • Deandrea M, Sung JY, Limone P, et al. Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid. 2015;25(8):890–896.
  • Cesareo R, Pasqualini V, Simeoni C, et al. Prospective study of effectiveness of ultrasound-guided radiofrequency ablation versus control group in patients affected by benign thyroid nodules. J Clin Endocrinol Metab. 2015;100(2):460–466.
  • Guang Y, He W, Luo Y, et al. Patient satisfaction of radiofrequency ablation for symptomatic benign solid thyroid nodules: our experience for 2-year follow up. BMC Cancer. 2019;19(1):147.
  • Hamidi O, Callstrom MR, Lee RA, et al. Outcomes of radiofrequency ablation therapy for large benign thyroid nodules: a mayo clinic case series. Mayo Clin Proc. 2018;93(8):1018–1025.
  • Cheng Z, Che Y, Yu S, et al. US-guided percutaneous radiofrequency versus microwave ablation for benign thyroid nodules: a prospective multicenter study. Sci Rep. 2017;7(1):9554.
  • Lim HK, Lee JH, Ha EJ, et al. Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol. 2013;23(4):1044–1049.
  • Sim JS, Baek JH, Lee J, et al. Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume. Int J Hyperthermia. 2017;33(8):905–910.
  • Døssing H, Bennedbaek FN, Hegedüs L. Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol. 2011;165(1):123–128.
  • Valcavi R, Riganti F, Bertani A, et al. Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid. 2010;20(11):1253–1261.
  • Wang B, Han ZY, Yu J, et al. Factors related to recurrence of the benign non-functioning thyroid nodules after percutaneous microwave ablation. Int J Hyperthermia. 2017;33(4):459–464.
  • Negro R, Greco G, Deandrea M, et al. Twelve-month volume reduction ratio predicts regrowth and time to regrowth in thyroid nodules submitted to laser ablation: a 5-year follow-up retrospective study. Korean J Radiol. 2020;21(6):764–772.
  • Bernardi S, Giudici F, Cesareo R, et al. Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the italian minimally invasive treatments of the thyroid group. Thyroid. 2020. DOI:10.1089/thy.2020.0202. Online ahead of print.
  • Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
  • Albrecht T, Blomley M, Bolondi L, EFSUMB Study Group, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med. 2004;25(4):249–256.
  • Russ G, Bonnema SJ, Erdogan MF, et al. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur Thyroid J. 2017;6(5):225–237.
  • Sim JS, Baek JH, Cho W. Initial ablation ratio: quantitative value predicting the therapeutic success of thyroid radiofrequency ablation. Thyroid. 2018;28(11):1443–1449.
  • Ma JJ, Ding H, Xu BH, et al. Diagnostic performances of various gray-scale, color Doppler, and contrast-enhanced ultrasonography findings in predicting malignant thyroid nodules. Thyroid. 2014;24(2):355–363.
  • Claudon M, Dietrich CF, Choi BI, European Federation of Societies for Ultrasound, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013;39(2):187–210.
  • Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis And Management Of Thyroid Nodules – 2016 update. Endocrine Practice. 2016;22(Supplement 1):1–60.
  • Schiaffino S, Serpi F, Rossi D, et al. Reproducibility of ablated volume measurement is higher with contrast-enhanced ultrasound than with B-mode ultrasound after benign thyroid nodule radiofrequency ablation-a preliminary study. J Clin Med. 2020;9(5):1054.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
  • Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127(2):208–223.
  • Wu F. Heat-based tumor ablation: role of the immune response. Adv Exp Med Biol. 2016;880:131–153.
  • Meloni MF, Andreano A, Franza E, et al. Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur J Radiol. 2012;81(8):e897-902–e902.
  • Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response. World J Surg. 2018;42(8):2476–2484.
  • Ohno T, Kawano K, Sasaki A, et al. Expansion of an ablated site and induction of apoptosis after microwave coagulation therapy in rat liver. J Hepatobiliary Pancreat Surg. 2001;8(4):360–366.
  • Jung SL, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for benign thyroid nodules: a prospective multicenter study. Korean J Radiol. 2018;19(1):167–174.
  • Baek JH, Lee JH, Sung JY, Korean Society of Thyroid Radiology, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–342.
  • Baek JH. Factors related to the recurrence of benign thyroid nodules after thermal ablation. Int J Hyperthermia. 2017;33(8):957–958.
  • Sim JS, Baek JH. Long-term outcomes following thermal ablation of benign thyroid nodules as an alternative to surgery: the importance of controlling regrowth. Endocrinol Metab. 2019;34(2):117–123.
  • Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017;18(4):615–623.
  • Zhao CK, Xu HX, Lu F, Sun LP, et al. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: first results of CEUS evaluation. CH. 2017;65(4):393–405.
  • Ahmed M, Brace CL, Lee FT, et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.